The impact of hydroxychloroquine and azithromycin on the corrected qt interval in patients with the novel Coronavirus disease 2019.
Bektas MuratHakan AkgunMuhittin AkarsuAhmet OzmenSelda MuratPublished in: Revista da Associacao Medica Brasileira (1992) (2021)
In this study, patients who received hydroxychloroquine for the treatment of COVID-19 were at high risk of QTc prolongation, and concurrent treatment with azithromycin was associated with greater changes in QTc.